4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-007403
General Counsel sold 1,302 shares at $0.67 ($873)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Miller Edward General Counsel | 2024-01-23 | Sale | −1,302 | $0.67 | $873 | 234,232 | D: show line 1 in the form |
| Open-market sales · 1,302 sh · avg $0.67 · $873 | |||||||
Loading xslF345X05/ownership.xml…